The study was funded by the National Library of Medicine, the National Institute of Child Health and Human Development, the Massachusetts Department of Public Health, the General Clinical Research Center at Children's Hospital Boston, and the Agency for Healthcare Research and Quality. Clarissa Valim, MD, ScD, of Children's Hospital Boston's Clinical Research Program and the Harvard School of Public Health, and Alexander J. McAdam, MD, Ph.D., of the Department of Laboratory Medicine at Children's, were co-authors.
*For further background, see:
Falsey AR; et al. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005 Apr 28;3 52(17):1749-59.
Thompson WW; et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003 Jan 8;289(2):179-86.
Hall CB; et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009 Feb 5; 360(6):588.
Founded in 1869 as a 20-bed hospital for children, Children's Hospital Boston today is one of the nation's leading pediatric medical centers, the primary pediatric teaching hospital of Harvard Medical School, and the largest provider of health care to Massachusetts children. In addition to 396 pediatric and adolescent inpatient beds and more than 100 outpatient programs, Children's houses the world's largest research enterprise based at a pediatric medical center, where its discoveries benefit both children and adults. More than 500 scientists, including eight members of the National'/>"/>
|Copyright©2009 PR Newswire.|
All rights reserved